Forbes, July 9 2017: Dr. Brenda Fitzgerald, the new CDC director, previously promoted unproven anti-aging treatments, raising concerns about her commitment to science-based medicine. NCHR and other health experts question whether her qualifications align with the CDC’s mission to rely on credible scientific evidence for public health decisions.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Special Report: Many Expensive New Cancer Drugs Are Useless (or Worse)
Bottom Line, July 3 2017: Many new cancer drugs are costly but aren’t proven to help patients live longer or improve their quality of life. We and other experts worry that fast FDA approvals are based on questionable evidence. Some drugs have serious side effects and don’t improve survival, yet they remain on the market for years, harming patients and costing patients and our healthcare system billions of dollars.
Read More »Morcellator Cancer Reports Drop, Essure Reports Rise
Drugwatch, June 20, 2017:Reports of cancer that was spread by power morcellators have decreased, while injuries from Essure sterilization (permanent birth control) devices have increased. We join other experts who are concerned about FDA’s reporting system and emphasize our support of the Medical Device Safety Act, which would improve the safety of medical devices
Read More »It’s Not Safe in Soap, But You Touch It Everyday
Marketwatch, June 21 2017: Some soaps contain triclosan and other chemicals that can disrupt hormones and be harmful to health. Experts say these ingredients offer little benefit and pose risks. The FDA has banned certain antibacterial agents in soaps, but these chemicals are still found in other products, raising concerns about daily exposure.
Read More »If Drug Companies Are ‘Getting Away With Murder,’ Trump May Grant Them a Pardon
STAT, June 19, 2017. Trump’s team is reportedly considering moves that would do little to address the problem — and would instead please the pharmaceutical industry.
Read More »